ULS vs. ARWR

Last updated Aug 1, 2026

ULS (UL Solutions Inc) and ARWR (Arrowhead Pharmaceuticals, Inc.) are both stocks. ULS operates in Specialty Business Services (Industrials), while ARWR operates in Biotechnology (Healthcare). Over the past year, ULS returned 28.31% vs 431.39% for ARWR. Their 0.15 correlation means their historical movements had little consistent relationship.

Performance

ULS vs. ARWR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in UL Solutions Inc (ULS) and Arrowhead Pharmaceuticals, Inc. (ARWR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ULS achieves a 16.58% return, which is significantly lower than ARWR's 27.50% return.

ULS

• 1D: -0.56%
• 1M: -5.52%
• 6M: 30.90%
• YTD: 16.58%
• 1Y: 28.31%
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: 54.71%

ARWR

• 1D: -3.06%
• 1M: 0.79%
• 6M: 22.10%
• YTD: 27.50%
• 1Y: 431.39%
• 3Y*: 35.96%
• 5Y*: 4.09%
• 10Y*: 30.88%
• ALL TIME*: -0.69%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
ARWR Arrowhead Pharmaceuticals, Inc.	$205.45M	$188.79M	$175.31M
ULS UL Solutions Inc	$63.17M	$75.57M	$90.09M

ULS vs. ARWR - Yearly Performance Comparison

	2026 (YTD)	2025	2024
ULS UL Solutions Inc	16.58%	59.33%	46.87%
ARWR Arrowhead Pharmaceuticals, Inc.	27.50%	253.14%	-26.79%

Correlation

The correlation between ULS and ARWR is 0.13, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.13
Correlation (All Time) Calculated using the full available price history since Apr 12, 2024	0.15

Fundamentals

Market Cap ULS : $18.44B ARWR : $11.92B
EPS ULS : $1.71 ARWR : -$2.16
PS Ratio ULS : 6.01 ARWR : 19.00
PB Ratio ULS : 13.99 ARWR : 20.13
Total Revenue (TTM) ULS : $3.11B ARWR : $622.01M
Gross Profit (TTM) ULS : $1.54B ARWR : $529.27M
EBITDA (TTM) ULS : $725.35M ARWR : -$168.38M

Return for Risk

ULS vs. ARWR — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ULS

ULS Risk / Return Rank: 66
ULS Sharpe Ratio Rank: 66
ULS Sortino Ratio Rank: 63
ULS Omega Ratio Rank: 65
ULS Calmar Ratio Rank: 68
ULS Martin Ratio Rank: 68

ARWR

ARWR Risk / Return Rank: 99
ARWR Sharpe Ratio Rank: 100
ARWR Sortino Ratio Rank: 99
ARWR Omega Ratio Rank: 98
ARWR Calmar Ratio Rank: 100
ARWR Martin Ratio Rank: 100

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ULS vs. ARWR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for UL Solutions Inc (ULS) and Arrowhead Pharmaceuticals, Inc. (ARWR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ULS	ARWR	Difference
Sharpe ratio: Return per unit of total volatility	0.62	6.69	-6.08
Sortino ratio: Return per unit of downside risk	1.20	5.72	-4.52
Omega ratio: Gain probability vs. loss probability	1.16	1.70	-0.54
Calmar ratio: Return relative to maximum drawdown	1.08	17.83	-16.75
Martin ratio: Return relative to average drawdown	2.44	51.66	-49.21

ULS vs. ARWR - Sharpe Ratio Comparison

The current ULS Sharpe Ratio is 0.62, which is lower than the ARWR Sharpe Ratio of 6.69. The chart below compares the historical Sharpe Ratios of ULS and ARWR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ULS vs. ARWR - Drawdown Comparison

The maximum ULS drawdown since its inception was -24.34%, smaller than the maximum ARWR drawdown of -99.24%. Use the drawdown chart below to compare losses from any high point for ULS and ARWR.

Drawdown Indicators

	ULS	ARWR	Difference
Max Drawdown Largest peak-to-trough decline	-24.34%	-99.24%	+74.90%
Max Drawdown (1Y) Largest decline over 1 year	-24.34%	-24.64%	+0.30%
Max Drawdown (3Y) Largest decline over 3 years	—	-74.70%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-87.89%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-88.96%	—
Current Drawdown Current decline from peak	-12.50%	-47.91%	+35.41%
Average Drawdown Average peak-to-trough decline	-6.01%	-81.07%	+75.06%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.76%	8.49%	+2.27%

Volatility

ULS vs. ARWR - Volatility Comparison

The current volatility for UL Solutions Inc (ULS) is 11.44%, while Arrowhead Pharmaceuticals, Inc. (ARWR) has a volatility of 23.10%. This indicates that ULS experiences smaller price fluctuations and is considered to be less risky than ARWR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ULS	ARWR	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.44%	23.10%	-11.66%
Volatility (6M) Calculated over the trailing 6-month period	31.61%	39.03%	-7.42%
Volatility (1Y) Calculated over the trailing 1-year period	42.62%	65.63%	-23.01%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	35.90%	64.63%	-28.73%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	35.90%	74.38%	-38.48%

Dividends

ULS vs. ARWR - Dividend Comparison

ULS's dividend yield for the trailing twelve months is around 0.60%, while ARWR has not paid dividends to shareholders.

Position	TTM	2025	2024
ARWR Arrowhead Pharmaceuticals, Inc.	0.00%	0.00%	0.00%
ULS UL Solutions Inc	0.60%	0.66%	0.75%

Financials

Frequently Asked Questions

Can I hold both ULS and ARWR in my portfolio?

ULS and ARWR have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ULS or ARWR?

ARWR has higher volatility (23.10%) compared to ULS (11.44%). In terms of maximum drawdown, ULS dropped -24.34% vs ARWR's -99.24%.

Which has better risk-adjusted returns?

ARWR currently has the higher Sharpe Ratio (6.69 vs 0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.